BSEBoard Meeting1d ago · 10 Nov 2026, 04:46 pm

Outcome of Board Meeting held today i.e. 10th November 2026

Suraksha Diagnostic Ltd · 544293

✦ AI SummaryResults

Suraksha Diagnostic Ltd's board meeting held on November 10, 2026, approved the unaudited financial results for the quarter and half year ended September 30, 2026. The results are enclosed with the limited review report issued by the statutory auditors. The financial results are also available on the company's website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suraksha Diagnostic Ltd - 544293 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 10Th November 2026

Attachments (1)

📄

f702baa8-5339-4493-98dc-fbf6e67d1851.pdf

pdf

Download →
View document text
Date: 10th November, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra - Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol: SURAKSHA Dear Sir / Ma’am, Sub: Outcome of the Board Meeting held today i.e. Tuesday, 10th November, 2026 Ref: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) as amended from time to time Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) as amended from time to time, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e. Tuesday, 10th November, 2026, inter alia, considered and approved/noted the following: 1. Approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026 and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company, pursuant to Regulation 33 of SEBI Listing Regulations marked as “Annexure-A”; The aforesaid financial results are also being made available on the Company’s website at www.surakshanet.com. Please note that the meeting commenced at 03:00 P.M. (IST) and concluded at 03:40 P.M. (IST) You are requested to take the same on record. Thanking you. For Suraksha Diagnostic Limited Shreya Arora Company Secretary & Compliance Officer Membership No.: 30892 Encl.: as above Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750